	Explainable and visualizable machine learning model development and validation for 5-year postoperative survival prediction in prostate cancer patients agedâ€‰â‰¥â€‰65 years. BMC Geriatr Cheng H, Shen T. PMID: 42082925 [PubMed - as supplied by publisher]
	Racial Disparities in Shared Decision Making Among Prostate Cancer Patients: A National Study. J Racial Ethn Health Disparities Daggolu J, Khalid J, Aparasu RR. PMID: 42082839 [PubMed - as supplied by publisher]
	Adaptive Knowledge Distillation for Anatomical Segmentation in Pelvic CT Imaging of Prostate Cancer. Ann Biomed Eng Karata, Demir B, Kaya A, Özkan E, Küçük NÖ. PMID: 42082797 [PubMed - as supplied by publisher]
	Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancer. J Immunother Cancer Bryant JM, Sandoval M, Putney R, Trivedi P, Katende EN, Fink A, Naqvi SM, Kim Y, Yin V, Zhang J, Park JY, Serna A, Lam N, Pow-Sang J, Poch M, Li R, Manley BJ, Naghavi A, Torres-Roca J, Grass GD, Kim S, Latifi K, Hunt D, Johnstone P, Dhillon J, Rodriguez PC, Jain R, Fernandez DC, Yamoah K. PMID: 42082271 [PubMed - indexed for MEDLINE]
	Outcomes of Radiotherapy With or Without Dose Escalation to Lymph Node Metastases Detected by PET PSMA or Conventional Imaging in Node-Positive Prostate Cancer: A Real-World Multicenter Propensity Score-Matched (PRIMENOD) Analysis. Clin Nucl Med Bilski M, Mastroleo F, Chyrek AJ, Kuncman , Lelek P, Stankiewicz M, Gomez-Iturriaga A, Miszczyk M, Burchardt W, Kluska A, Napieralska A, Kukie, Konat-B, Stando R, Dec M, Piliszczuk E, Matys R, Bajon T, Trojanowski M, Chiche, Wojcieszek P, Fijuth J, Zilli T, Kishan A, Jereczek-Fossa BA. PMID: 42081701 [PubMed - indexed for MEDLINE]
	Automated counting of prostate cell types with image processing and machine learning. PLoS One Azad BKD, Hakimi AN, Tabatabaei SM, Arezouchi BM, Keshtiban MM, Mirzaei A, Nafian F, Khatami F, Aghamir MK, Kolahdouz M. PMID: 42081477 [PubMed - indexed for MEDLINE]
	Face and content validation of TURP and TURB simulation models: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group Study. World J Urol Sener TE, de Oliveira TR, Demirkiran ED, Perri D, Pereira S, Caballero JP, Osorio L, Kartalas IG, Ramos R, Castro AS, Reis DO, Paciotti M, Mariappan P, Diana P, Dragos L, Veneziano D, Biyani CS, Somani B, Liatsikos E. PMID: 42081043 [PubMed - indexed for MEDLINE]
	Comment on "sexual distress in patients after radical cystectomy for bladder cancer: a qualitative study". Support Care Cancer Qiu Z, Xia X, Li X. PMID: 42080949 [PubMed - in process]
	Development and clinical deployment of an automated planning tool for prostate only and male whole pelvis plans based on multi-criteria optimization. J Appl Clin Med Phys Huang K, Wang K, Schrum A, Kusmaul E, Fisler E, Guerrero M. PMID: 42080772 [PubMed - indexed for MEDLINE]
	The role of AI in prostate cancer care: Assessing the role of chatbots versus urologists in patient communication and empathy. Urologia Cacciatore L, Minore A, Contessa P, Raso G, Iannello AR, Papalia R, Esperto F. PMID: 42080545 [PubMed - as supplied by publisher]
	SPRINTR: Swedish PRecision medicine Initiative for Novel Treatments and Research-towards efficient recruitment to clinical trials for prostate cancer. Acta Oncol Welén K, Josefsson A, SPRINTR study group. PMID: 42080506 [PubMed - in process]
	Research progress in augmentation strategies for PD-1/PD-L1 inhibitors in bladder cancer: from biological determinants to clinical applications. Front Immunol Cheng Y, Deng W, Liu Y, Chen G, Cao K. PMID: 42079635 [PubMed - indexed for MEDLINE]
	Modern proton therapy in prostate cancer: precision in practice. Front Oncol Yacoub I, Khalil J, Wei S, Hsieh K, Chhabra AM, Mehta KJ, Oska C, Zhu L, Choi JI, Simone CB 2nd. PMID: 42078815 [PubMed]
	Calvert Formula Modification for Optimized Carboplatin Dosing in Breast Cancer with Preserved Renal Function. Pharmaceutics Jeon J, Jeon J, Dang HT, Choi EH, Kang SY, Yun HY, Chae JW, Kim JH, Lee S. PMID: 42076051 [PubMed]
	Possible Role of Diffusion-Weighted Imaging in Prediction of Prostate Cancer Grade Group Upgrading: Insights from Biopsy to Radical Prostatectomy. Medicina (Kaunas) , Skrobisz K, Sowa M, P, Panas D, Grzywi, Matuszewski M, Szurowska E. PMID: 42075621 [PubMed - indexed for MEDLINE]
	Positron Emission Tomography/Computed Tomography in Bladder Cancer: The Role of [(18)F]FDG and Non-FDG Radiotracers. Medicina (Kaunas) Fali, Witkowska-Patena E, Krzy, Dziuk M. PMID: 42075575 [PubMed - indexed for MEDLINE]
	The Outcome of Immediate Adjuvant Postoperative External Beam Radiotherapy Versus Observation Alone After Radical Prostatectomy in High-Risk Prostate Cancer: A Meta Analysis. J Clin Med Borhan W, Rajih E. PMID: 42074951 [PubMed]
	Antihypertensive Therapy and Survival Outcomes in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study. J Clin Med , Y, Ate. PMID: 42074795 [PubMed]
	Prevalence of Benign Prostatic Hyperplasia and Prostate Cancer Among Men Presenting with Lower Urinary Tract Symptoms at a Tertiary Referral Hospital in Dar es Salaam, Tanzania: A Retrospective Cross-Sectional Study. J Clin Med Amin AIA, Samhan LM, Zaidi ARZ, Ali Amin AI, Faroog Z, Almalki BSR, Alghalyini B. PMID: 42074717 [PubMed]
	Serum Trimethylamine-N-Oxide and Its Precursors as a Diagnostic Biomarker Panel for Non-Muscle-Invasive Bladder Cancer. Int J Mol Sci Baltac, Acar O, Sönmez C, Sa, Argun ÖB, Kural AR, Y, , Serdar MA, Özp. PMID: 42074229 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 177994

Page 1 of 8900



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy